rifampicin
Showing 26 - 50 of 100
Infections, Bacterial Trial in Las Vegas (Gepotidacin, Cimetidine, Rifampicin)
Completed
- Infections, Bacterial
- Gepotidacin
- +5 more
-
Las Vegas, NevadaGSK Investigational Site
Dec 9, 2021
Healthy Trial in Changsha (ASC40, Itraconazole, rifampicin)
Completed
- Healthy
- ASC40
- +2 more
-
Changsha, Hunan, ChinaHunan provincial people's hospital
Aug 19, 2021
Tuberculosis, Pulmonary Tuberculosis, HIV Coinfection Trial in Johannesburg (Isoniazid, Rifampicin, Ethambutol)
Recruiting
- Tuberculosis
- +2 more
- Isoniazid
- +4 more
-
Johannesburg, Gauteng, South AfricaTembisa Clinical Research Centre-The Aurum Institute
Jun 8, 2022
Lung Infection, Mycobacterium Avium Complex Trial in Amiens, Marseille (Clarithromycin 1000 MG, Azithromycin 250 mg, Rifampicin)
Recruiting
- Lung Infection
- Mycobacterium Avium Complex
- Clarithromycin 1000 MG
- +3 more
-
Amiens, Picardie, France
- +1 more
Aug 23, 2021
Four Months Moxifloxacin Containing Daily Regimen Study Among
Not yet recruiting
- Tuberculosis, Pulmonary
- Isoniazid
- +4 more
-
Chennai, Tamilnadu, IndiaNational Institute for Research in Tuberculosis
Sep 29, 2021
Tuberculosis, Pulmonary Trial in Seoul (High-dose rifampicin, Isoniazid, Pyrazinamide)
Not yet recruiting
- Tuberculosis, Pulmonary
- High-dose rifampicin
- +4 more
-
Seoul, Korea, Republic ofDivision of Pulmonology and Critical Care Medicine, Department o
Jul 21, 2020
Biological Availability Trial in Mannheim, Mönchengladbach (levonorgestrel/ Microlut, Norethindrone/ Noriday, Desogestrel/
Completed
- Biological Availability
- levonorgestrel/ Microlut
- +6 more
-
Mannheim, Baden-Württemberg, Germany
- +1 more
Apr 14, 2020
Healthy Male Subjects Trial in Hangzhou (Fluzoparib, Rifampicin)
Completed
- Healthy Male Subjects
- Fluzoparib
- Rifampicin
-
Hangzhou, Zhejiang, ChinaFirst Affiliated Hospital of Zhejiang University School of Medic
Feb 25, 2020
Parkinson's Disease Trial in Sumida-ku (KW-6356, Clarithromycin, Rifampicin)
Completed
- Parkinson's Disease
- KW-6356
- +2 more
-
Sumida-ku, Tokyo, JapanMedical Co. LTA Sumida Hospital
Nov 27, 2019
Healthy Trial in Mannheim (BI 894416, Rifampicin)
Completed
- Healthy
- BI 894416
- Rifampicin
-
Mannheim, GermanyCRS Clinical Research Services Mannheim GmbH
Oct 22, 2019
Healthy Volunteers Trial in Groningen (Balovaptan, Rifampicin)
Completed
- Healthy Volunteers
- Balovaptan
- Rifampicin
-
Groningen, NetherlandsPra International Group B.V
Oct 15, 2019
Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) Trial in Japan (Bedaquiline, Clarithromycin, Ethambutol)
Recruiting
- Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
- Bedaquiline
- +4 more
-
Aichi, Japan
- +42 more
Jan 17, 2023
Adverse Drug Interactions Trial in Seattle (Rifampicin, sulforaphane plus rifampicin, sulforaphane alone)
Completed
- Adverse Drug Interactions
- Rifampicin
- +2 more
-
Seattle, Washington
- +1 more
Aug 15, 2019
Tuberculosis Trial in Busan, Seoul (Rifampicin, Isoniazid, Pyrazinamide)
Completed
- Tuberculosis
- Rifampicin
- +4 more
-
Busan, Korea, Republic of
- +2 more
Dec 6, 2019
Respiratory Syncytial Virus Infections Trial in London (Itraconazole, Verapamil, Rifampicin)
Completed
- Respiratory Syncytial Virus Infections
- Itraconazole
- +5 more
-
London, United KingdomRichmond Pharmacology Ltd
May 22, 2019
Infective Endocarditis Trial in France (Levofloxacin, Rifampicin, Conventional IV treatment of staphylococci IE following
Recruiting
- Infective Endocarditis
- Levofloxacin
- +2 more
-
Aix en Provence, France
- +53 more
May 18, 2021
Antiretroviral Drugs and Related Drugs During and After
Pulmonary Tuberculosis (TB) Trial in Bellville, Mowbray (Rifampicin)
Completed
- Pulmonary Tuberculosis (TB)
- Rifampicin
-
Bellville, South Africa
- +1 more
Nov 23, 2018
Tuberculosis, Pulmonary Trial in Worldwide (Rifampicin, Isoniazid, Pyrazinamide)
Unknown status
- Tuberculosis, Pulmonary
- Rifampicin
- +8 more
-
Bandung, Indonesia
- +13 more
Apr 18, 2019
Healthy Subjects Trial in Groningen (Clazosentan, Rifampicin, Saline (0.9% sodium chloride))
Completed
- Healthy Subjects
- Clazosentan
- +2 more
-
Groningen, NetherlandsQPS Netherlands B.V.
Oct 22, 2018